Amniotic membrane effective in GVHD-induced dry eye disease

In patients with dry eye disease caused by ocular graft-vs.-host disease, Marta Ponce Contreras, MD, and colleagues found cryopreserved amniotic membrane treatment improved ocular signs and symptoms in patients whose disease was refractory to conventional therapy.
Corneal manifestations of ocular GVHD disease can be severe, leading to corneal erosion, thinning, ulceration and perforation. Early identification and treatment, with regular follow-up visits are important to prevent progression, the authors said in a poster presented at the virtual American Society of Cataract and Refractive

Full Story →